OS Therapies Inc（OSTX）财务数据OSTXOS Therapies Inc

In the context of the broader market, OSTX competes directly with industry leaders such as CGTX and CSBR. With a market capitalization of $45.51M, it holds a significant position in the sector. When comparing efficiency, OSTX's gross margin of N/A stands against CGTX's N/A and CSBR's 50.54%. Such benchmarking helps identify whether OS Therapies Inc is trading at a premium or discount relative to its financial performance.

The company has reported continuous net losses, with Q1 2026 showing a net operating loss of $10.4 million, a 167% increase from the previous year. The gross profit remains negative, and the current ratio has dropped significantly, indicating financial distress.